ADMP Adamis Pharmaceuticals Corp

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.

$0.12  +0.02 (14.61%)
As of 03/22/2023 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  149,983,265
Average volume:  3,838,255
Market cap:   $23,997,322
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy